Sink-traps are a major source for carbapenemase-producing


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
27 Dec 2023
Historique:
medline: 27 12 2023
pubmed: 27 12 2023
entrez: 27 12 2023
Statut: aheadofprint

Résumé

We studied the extent of carbapenemase-producing Enterobacteriaceae (CPE) sink contamination and transmission to patients in a nonoutbreak setting. During 2017-2019, 592 patient-room sinks were sampled in 34 departments. Patient weekly rectal swab CPE surveillance was universally performed. Repeated sink sampling was conducted in 9 departments. Isolates from patients and sinks were characterized using pulsed-field gel electrophoresis (PFGE), and pairs of high resemblance were sequenced by Oxford Nanopore and Illumina. Hybrid assembly was used to fully assemble plasmids, which are shared between paired isolates. In total, 144 (24%) of 592 CPE-contaminated sinks were detected in 25 of 34 departments. Repeated sampling (n = 7,123) revealed that 52%-100% were contaminated at least once during the sampling period. Persistent contamination for >1 year by a dominant strain was common. During the study period, 318 patients acquired CPE. The most common species were CPE-contaminated sinks are an important source of transmission to patients. Although traditionally person-to-person transmission has been considered the main route of CPE transmission, these data suggest a change in paradigm that may influence strategies of preventing CPE dissemination.

Identifiants

pubmed: 38149351
pii: S0899823X23002702
doi: 10.1017/ice.2023.270
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Auteurs

Gili Regev-Yochay (G)

Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.
Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ili Margalit (I)

Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.
Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Gillian Smollan (G)

Microbiology laboratory, Sheba Medical Center, Ramat-Gan, Israel.

Rotem Rapaport (R)

Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.
Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ilana Tal (I)

Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.

William P Hanage (WP)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.

Nani Pinas Zade (N)

Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.

Hanaa Jaber (H)

Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.

Bradford P Taylor (BP)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.

You Che (Y)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.

Galia Rahav (G)

Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Infectious Disease Unit, Sheba Medical Center, Ramat-Gan, Israel.

Eyal Zimlichman (E)

Sheba Medical Center Management, Ramat-Gan, Israel.

Nati Keller (N)

Microbiology laboratory, Sheba Medical Center, Ramat-Gan, Israel.
Ariel University, Ari'el, Samaria.

Classifications MeSH